This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.


Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


2ds1

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:2ds1.jpg|left|200px]]
+
{{Seed}}
 +
[[Image:2ds1.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_2ds1| PDB=2ds1 | SCENE= }}
{{STRUCTURE_2ds1| PDB=2ds1 | SCENE= }}
-
'''Human cyclin dependent kinase 2 complexed with the CDK4 inhibitor'''
+
===Human cyclin dependent kinase 2 complexed with the CDK4 inhibitor===
-
==Overview==
+
<!--
-
The design of a novel series of cyclin-dependent kinase (CDK) inhibitors containing a macrocyclic quinoxaline-2-one is reported. Structure-based drug design and optimization from the starting point of diarylurea 2, which we previously reported as a moderate CDK1,2,4,6 inhibitor [J. Biol.Chem.2001, 276, 27548], led to the discovery of potent CDK1,2,4,6 inhibitor that were suitable for iv administration for in vivo study.
+
The line below this paragraph, {{ABSTRACT_PUBMED_16876403}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 16876403 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_16876403}}
==About this Structure==
==About this Structure==
Line 27: Line 31:
[[Category: Inhibition]]
[[Category: Inhibition]]
[[Category: Protein kinase]]
[[Category: Protein kinase]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 01:04:39 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 10:40:15 2008''

Revision as of 07:40, 28 July 2008

Template:STRUCTURE 2ds1

Human cyclin dependent kinase 2 complexed with the CDK4 inhibitor

Template:ABSTRACT PUBMED 16876403

About this Structure

2DS1 is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Structure-based drug design of a highly potent CDK1,2,4,6 inhibitor with novel macrocyclic quinoxalin-2-one structure., Kawanishi N, Sugimoto T, Shibata J, Nakamura K, Masutani K, Ikuta M, Hirai H, Bioorg Med Chem Lett. 2006 Oct 1;16(19):5122-6. Epub 2006 Jul 28. PMID:16876403

Page seeded by OCA on Mon Jul 28 10:40:15 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools